Increased platelet aggregation after heart transplantation: influence of aspirin.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  The Journal of Heart and Lung Transplantation

• Publication date

  1991-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 1911805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Early aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients: A pediatric heart transplant society analysis.

  2022cites this paper
• Platelet aggregation and response to aspirin therapy in cardiac allograft vasculopathy.

  2020cites this paper
• Lower Platelet Count Following Rabbit Antithymocyte Globulin Induction Is Associated With Less Acute Cellular Rejection in Heart Transplant Recipients.

  2020cites this paper
• Increased platelet reactivity after heart transplantation

  2020cites this paper
• Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy.

  2020cites this paper
• Factor VIIa administration in orthotopic heart transplant recipients and its impact on thromboembolic events and post-transplant outcomes

  2018cites this paper
• Early aspirin use and the development of cardiac allograft vasculopathy.

  2017cites this paper
• Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long‐term follow‐up

  2017cites this paper
• Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation.

  2016cites this paper
• Riociguat: A Novel New Drug for Treatment of Pulmonary Hypertension

  2015cites this paper
• Medication Management of Cardiac Allograft Vasculopathy After Heart Transplantation

  2015cites this paper
• Dietary Intervention in Coronary Care Units and in Secondary Prevention

  2011cites this paper
• Orthotopic heart transplantation: ten years' clinical experience.

  2008cites this paper
• Early postoperative left atrial thrombosis in a biatrial orthotopic heart transplant recipient successfully treated by intravenous heparin.

  2008cites this paper
• Cardiac allograft vasculopathy: an update.

  2007cites this paper
• Trapidil decreases the aggregation of platelets from heart transplant recipients ex vivo.

  2006cites this paper
• Thromboembolism in Heart Transplantation: Role of Prothrombin G20210A and Factor V Leiden

  2005cites this paper
• Thromboembolism in heart transplantation: role of prothrombin G20210A and factor V Leiden.

  2005cites this paper
• Platelet activation in heart transplant recipients

  2004cites this paper
• Platelet activation in heart transplant recipients.

  2004cites this paper
• Systemic embolism: a serious complication after cardiac transplantation avoidable by bicaval technique q

  2001cites this paper
• Systemic embolism: a serious complication after cardiac transplantation avoidable by bicaval technique.

  2001cites this paper
• [Incidence and dynamic behavior of spontaneous echocardiographic contrast and atrial thrombi in the transplanted heart].

  2001cites this paper
• Incidencia y comportamiento dinámico del contraste ecocardiográfico espontáneo y del trombo auricular en el corazón trasplantado

  2001cites this paper
• Coagulation markers predicting cardiac transplant rejection.

  2001cites this paper
• Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy.

  2000cites this paper
• Immunohistochemical characterization of coronary thrombi in allograft vascular disease.

  2000cites this paper
• Effect of angiopeptin and aspirin on accelerated graft atherosclerosis in transplanted mouse heart.

  1999cites this paper
• Successful Streptokinase Lysis of a Right-Atrial Thrombus in a Heart-Transplant Recipient

  1999cites this paper
• Ticlopidine increases nitric oxide generation in heart-transplant recipients: a possible novel property of ticlopidine.

  1998cites this paper
• Hemostatic/Fibrinolytic Predictors of Allograft Coronary Artery Disease after Cardiac Transplantation

  1997cites this paper
• A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients

  1997cites this paper
• Lipid metabolism alteration and treatment in heart transplant recipients

  1997cites this paper
• Fenofibrate, probucol, and other lipid-lowering treatments in heart transplant recipients.

  1996cites this paper
• Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia.

  1996cites this paper
• Clinically Significant Drug Interactions with Cyclosporin An Update

  1996cites this paper
• High prevalence of thromoembolic complications in heart transplant recipients. Which preventive strategy.?

  1996cites this paper
• Thrombin Generation in Myocardial Infarction and Hypercholesterolemia: Effects of Aspirin

  1995cites this paper
• Increased production of reactive oxygen species in pharmacologically-immunosuppressed patients.

  1994cites this paper
• Effects of a French Mediterranean diet on heart transplant recipients with hypercholesterolemia.

  1994cites this paper
• [Oxidative stress and lipid-protein peroxidation after cardiac transplantation. New hypotheses for explaining pathogenesis of accelerated forms of ischemic heart disease].

  1994cites this paper
• Naftidrofuryl inhibits the release of 5-hydroxytryptamine and platelet-derived growth factor from human platelets.

  1994cites this paper
• THE BENEFICIAL EFFECT OF DIETARY ANTIOXIDANT SUPPLEMENTATION ON PLATELET AGGREGATION AND CYCLOSPORINE TREATMENT IN HEART TRANSPLANT RECIPIENTS

  1994cites this paper
• Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients.

  1994cites this paper
• Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients.

  1993cites this paper
• Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis.

  1993cites this paper
• Evaluation of ticlopidine, a novel inhibitor of platelet aggregation, in heart transplant recipients.

  1993cites this paper
• Accelerated coronary artery disease after heart transplantation: the role of enhanced platelet aggregation and thrombosis

  1993cites this paper
• Ischaemic heart disease, cardiac surgery and heart/heart-lung transplantation reviewed from a haematological perspective.

  1993cites this paper
• Accelerated coronary artery disease after heart transplantation: the role of enhanced platelet aggregation and thrombosis

  1993cites this paper
• Coronary artery disease after heart transplantation: clinical aspects

  1992cites this paper
• Platelet function and composition in heart transplant recipients compared with nontransplanted coronary patients.

  1992influential citation